Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  British medical journal

• Publication date

  1987-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.294.6581.1197-aPMID 2954609PMCID PMC1246359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intestinal obstruction due to schistosomiasis.

  1985cited by this paper
• Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.

  1984cited by this paper
• Calcium chelators increase airway responsiveness.

  1984cited by this paper
• The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection

  1983cited by this paper
• Importance of calcium in citric acid-induced airway constriction.

  1983cited by this paper
• Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen.

  1981cited by this paper
• Pathology of tropical and extraordinary diseases

  1979cited by this paper
• Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.

  1979cited by this paper
• Bronchial reactivity to inhaled histamine: a method and clinical survey

  1977cited by this paper
• Comparative trial of influenza vaccines. II. Adverse reactions in children and adults.

  1976cited by this paper
• Selective solubilization of hemagglutinin and neuraminidase from influenza viruses.

  1975cited by this paper

• Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial.

  2026cites this paper
• Polymyxin B and ethylenediaminetetraacetic acid act synergistically against Pseudomonas aeruginosa and Staphylococcus aureus

  2024cites this paper
• Quaternary ammonium compounds in hypersensitivity reactions

  2022cites this paper
• Asthma‐inducing potential of 28 substances in spray cleaning products—Assessed by quantitative structure activity relationship (QSAR) testing and literature review

  2021influential citation
• Strategies for pulmonary delivery of drugs

  2020cites this paper
• Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists

  2020cites this paper
• Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease

  2020cites this paper
• AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria

  2020cites this paper
• Methodological evaluation of human research on asthmagenicity and occupational cleaning: a case study of quaternary ammonium compounds (“quats”)

  2019cites this paper
• Effects of benzalkonium chloride on cell viability, inflammatory response, and oxidative stress of human alveolar epithelial cells cultured in a dynamic culture condition.

  2019cites this paper
• Sterility and Stability Testing of Preservative-free Albuterol.

  2019cites this paper
• Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC

  2017cites this paper
• Benzalkonium Chloride: A Bronchoconstricting Preservative in Continuous Albuterol Nebulizer Solutions

  2017cites this paper
• Effectsof Ipratropium BromideNebulizer SolutionwithandwithoutPreservatives in theTreatment of AcuteandStableAsthma

  2017cites this paper
• Systemic Toxicity of Drugs Applied to the Eye

  2016cites this paper
• Comparison ofRESPIMATWithConventional Metered-Dose Inhalers WithandWithout Spacer

  2015cites this paper
• Importance of specific inhalation challenge in the diagnosis of occupational asthma induced by quaternary ammonium compounds.

  2015cites this paper
• Skin Allergy Caused by Organic Acid Anhydrides

  2014cites this paper
• Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies

  2014cites this paper
• BRITISH BIOMEDICAL BULLETIN

  2014cites this paper
• Contact Urticaria Caused by Preservatives and Disinfectants

  2014cites this paper
• Occupational rhinitis and asthma due to EDTA-containing detergents or disinfectants.

  2012cites this paper
• Angioedema y broncoconstricción paradójica secundarios a bromuro de ipratropio/salbutamol administrados por inhalador de dosis medida en pacientes alérgicos a la soya

  2011cites this paper
• Another plausible explanation for mist inhaler’s toxicity

  2011cites this paper
• Compatibility and Aerosol Characteristic of Formoterol Fumarate Mixed with Other Nebulizing Solutions

  2008cites this paper
• Benzalkonium Chloride Induced Bronchoconstriction in Patients with Stable Bronchial Asthma

  2007cites this paper
• Advanced techniques in the diagnosis and management of infectious pulmonary diseases in horses.

  2006cites this paper
• OBSTRUCTIVE AIRWAYS DISEASE Cleaning Products-Related Asthma

  2006cites this paper
• Cleaning Products-related Asthma

  2006cites this paper
• How Can Foods, Additives, and Drugs Affect the Patient With Asthma?

  2006cites this paper
• GINA Workshop Report (Updated 2004) Global Strategy for Asthma Management and Prevention

  2005cites this paper
• Low Incidence of Paradoxical Bronchoconstriction with Bronchodilator Drugs Administered by Respimat® Soft Mist™ Inhaler: Results of Phase II Single-Dose Crossover Studies

  2004cites this paper
• Anticholinergic agents for chronic asthma in adults.

  2004cites this paper
• Inner-City Availability of Preservative-Containing Albuterol

  2004cites this paper
• Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques

  2003cites this paper
• Sensory Nerves, Neurogenic Inflammation and Pain: Missing Components of Alternative Irritation Strategies? A Review and a Potential Strategy

  2003cites this paper
• Chapter 42 – Drugs

  2002cites this paper
• Inhaled antibiotic therapy: What drug? What dose? What regimen? What formulation?

  2002cites this paper
• Muscarinic Receptors in Airways Diseases

  2001cites this paper
• Efficacy and safety of aerosolized tobramycin in cystic fibrosis

  2001cites this paper
• Novel perspectives in anticholinergic therapy

  2001cites this paper
• Pulmonary function response to EDTA, an additive in nebulized bronchodilators.

  2001cites this paper
• Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions.

  2001cites this paper
• Aerossolterapia nas doenças respiratórias em eqüinos

  2001cites this paper
• Foods, Additives, and Nonsteroidal Anti-Inflammatory Drugs in Asthma

  2001cites this paper
• Laryngospasm and paradoxical bronchoconstriction after repeated doses of beta 2-agonists containing edetate disodium.

  2000cites this paper
• Post‐inhalation bronchoconstriction by beclomethasone dipropionate: A comparison of two different CFC propellant formulations in asthmatics

  2000cites this paper
• Long‐Term Use of Preservatives on Rat Nasal Respiratory Mucosa: Effects of Benzalkonium Chloride and Potassium Sorbate

  2000cites this paper
• Quaternary ammonium compounds and occupational asthma

  2000cites this paper
• Drug-Induced Respiratory Disorders

  2000cites this paper
• Laryngospasm and Paradoxical Bronchoconstriction After Repeated Doses

  2000cites this paper
• Clinical Pharmacology

  2000cites this paper
• Problems with inhalational drug delivery

  1999cites this paper
• [Bronchospasm caused by nebulized solution of salbutamol].

  1999cites this paper
• Inhalation therapy of equine respiratory disorders

  1999cites this paper
• Bronchoconstrictor additives in bronchodilator solutions.

  1999cites this paper
• Is beta-adrenergic-mediated airway relaxation of salmeterol antagonized by its solvent xinafoic acid?

  1999cites this paper
• Preservatives in Nebulizer Solutions: Risks without Benefit

  1998cites this paper
• Evaluation of benzalkonium chloride chemoneurolytic proximal gastric vagotomy

  1998cites this paper
• “ Inactive ” Ingredients in Pharmaceutical Products : Update ( Subject Review )

  1998cites this paper
• Management of Severe Asthma

  1998cites this paper
• Drug-induced Asthma

  1998cites this paper
• “ Inactive ” Ingredients in Pharmaceutical Products : Update ( Subject Review )

  1998cites this paper
• “ Inactive ” Ingredients in Pharmaceutical Products : Update ( Subject Review )

  1998cites this paper
• A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution.

  1997cites this paper
• "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs.

  1997cites this paper
• Aerosol therapy in the equine species.

  1997cites this paper
• 'Inactive' ingredients in pharmaceutical products: Update (subject review)

  1997cites this paper
• The science of nebulised drug delivery

  1997cites this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cites this paper
• Anticholinergic antimuscarinic agents in the treatment of airways bronchoconstriction in children

  1996cites this paper
• AMERICAN ACADEMY OF PEDIATRICS

  1996cites this paper
• ADVERSE REACTIONS TO FOOD AND DRUG ADDITIVES

  1996cites this paper
• Adverse Drug Events Related to Dosage Forms and Delivery Systems

  1996cites this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cites this paper
• Effects of Some Preservative Agents on Rat and Guinea Pig Tracheal and Human Nasal Ciliary Beat Frequency

  1996cites this paper
• FOOD AND DRUG ADDITIVES

  1995cites this paper
• Nebulized bacteriostatic saline as a cause of bronchitis.

  1995cites this paper
• Corticosteroid withdrawal restores responses to calcium chelators and enhances cholinergic responsiveness.

  1993cites this paper
• A case report: sensitivity to benzalkonium chloride.

  1993cites this paper
• Importance of prostanoids in calcium chelator-induced airway constriction.

  1993cites this paper
• Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies.

  1993cites this paper
• Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.

  1993cites this paper
• Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma.

  1992cites this paper
• Inhaled therapy in infants: Why not nebulize glucocorticoids?

  1992cites this paper
• Possible Association of Benzalkonium Chloride in Nebulizer Solutions with Respiratory Arrest

  1992cites this paper
• Paradoxical response to nebulized ipratropium bromide in pre-term infants asymptomatic at follow-up.

  1991cites this paper
• Treatment of the Elderly Asthmatic Patient with Heart Disease

  1991cites this paper
• Chronic persistent asthma: nebulizers and therapy additional to inhaled beta-agonists and steroids.

  1991cites this paper
• Calcium channel blockers modulate airway constriction in the canine lung periphery.

  1991cites this paper
• Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity.

  1991cites this paper
• A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.

  1991cites this paper
• The effect of benzalkonium chloride on the bronchodilator response to salbutamol nebuliser solution.

  1990cites this paper
• Effect of inhaled preservatives on asthmatic subjects. II. Benzalkonium chloride.

  1990cites this paper
• Pulmonary and Allergy

  1990cites this paper
• Home nebulizers: can optimal therapy be predicted by laboratory studies?

  1990cites this paper
• The airways effects of inhaled chlorbutol in asthmatic subjects.

  1990cites this paper
• Calcium chelators induce bronchoconstriction in the canine lung periphery.

  1990cites this paper
• Adverse reactions to inhaled drugs.

  1990cites this paper
• Paradoxical bronchospasm associated with the use of inhaled beta agonists.

  1990cites this paper